- PharmaTher Holdings (PHRM) has been included in the North American Psychedelics Index
- The index is designed to provide exposure to North American publicly-listed life sciences companies focused on psychedelic medicines
- The Horizons Psychedelic Stock Index Exchange Traded Fund invests in companies in the psychedelics industry engaged in legal activities involving psychedelic drugs and substances
- PharmaTher is one of twenty-four companies to have met the requirements of listing within the ETF
- PharmaTher Holdings is a biotech company focused on the use of psychedelics to treat mental health, neurological and pain disorders
- PharmaTher Holdings Ltd. (PHRM) opened trading at C$0.79 per share
PharmaTher Holdings (PHRM) has been included in the North American Psychedelics Index.
The North American Psychedelics Index is the underlying index of the Horizons Psychedelic Stock Index Exchange Traded Fund (NEO: PSYK).
The index is designed to provide exposure to North American publicly-listed life sciences companies focused on psychedelic medicines and to provide diversified exposure to the psychedelics industry.
The ETF invests in companies in the psychedelics industry engaged in legal activities involving psychedelic drugs and substances.
PharmaTher is one of twenty-four companies to have met the requirements of listing within the ETF.
Fabio Chianelli, Chief Executive Officer of PharmaTher said,
“We are pleased to be included in the first-ever Psychedelic ETF as a recognition of our accomplishments in the advancement of prescription-based psychedelic pharmaceuticals. The inclusion into the Index and ETF not only broadens our investor awareness, but also provides us with greater confidence in our business model that focuses on the research, development and commercialization of novel uses, formulations and delivery forms of ketamine for mental health (i.e. Depression), rare and near-rare neurological (i.e. Parkinson’s disease, Amyotrophic lateral sclerosis), and pain disorders.
The ETF is managed by Horizons ETF Management an innovative financial services company offering one of the largest suites of exchange-traded funds in Canada.
PharmaTher Holdings is a clinical-stage psychedelics biotech company focused on the research, development and commercialization of novel uses, formulations and delivery methods of psychedelics to treat mental health, neurological and pain disorders.
PharmaTher Holdings Ltd. (PHRM) opened trading at C$0.79 per share.
